Issue #12, September 2002

Small-Cap Tsunamis: How Scott Sterling Johnston Gets in Front of the Wave

By Richard Hefter, Editor, Small Cap Manager

Scott Sterling Johnston’s Micro Cap Aggressive Growth portfolio was ranked #1 for the last year, three years and five years through June 30, 2002 by Pensions & Investments. It’s a fact that Johnston, a 30-year industry veteran, mentions to us late in our interview, an afterthought among numerous industry accolades.

Johnston is the principal of San Francisco-based Sterling Johnston Capital Management, which runs small-cap and micro-cap managed accounts and two hedge funds, and has grown its managed assets from $50 million in 1996 to $600 million today.

Johnston began his career an auditor with Andersen Consulting and later joined Smith Barney & Co. as an institutional salesman. He was chief executive of Security Pacific Bank's investment advisory subsidiary from 1981 to 1985, where he started the Pacific Horizon family of mutual funds and was responsible for over $5 billion in managed assets. Prior to founding Sterling Johnston in 1996, he built Apodaca-Johnston Capital Management from $10 million in assets in 1994 to over $500 million in 1996, with one of the top performance records in the country.

What professional experience has most influenced you as a small-cap manager today?

I believe my sell-side experience as an institutional salesman for Smith Barney in New York was an important formative experience. It helped me understand the way Wall Street develops an idea, packages an idea, and sells an idea. I learned that stocks are really sold, not bought. If you’re a money manager and can understand the way catalysts and stories develop, and how a stock’s story can create imagination and the fire that will drive that stock much higher, you can use that to often get in front of the story and in front of that big marketing effort on the Street.

Another thing I learned is that when an institution wakes up and decides they really have to own a stock or a theme or industry, it creates this giant tidal wave, this giant tsunami that can push that stock to the moon because you’ve got this huge amount of money flowing into a name. So I’ve discovered a long time ago that if there’s some way I can get in front of that big wave of institutional buying power when these folks just have to be there, or conversely sell or short stocks in front of that big move, you can really use that tsunami to your advantage.

How do you get ahead of that wave?

The way we know it’s going to hit is is we get an early call from the regional brokerage firms we do business with. We do business with over 120 regional firms, resulting in a massive amount of information. We want that information. We call it the information advantage. We feel that the regionals likely have a closer pipeline to what the company is really doing than your big huge investment banks because the companies are in their own back yard. So you’ve got a higher quality line of information, but also I’ve got relationships now that go back with these regional firms 20-25 years. So I’ve got that human element, and while we have a healthy skepticism of the conflicts that exist between research and investment banking, we have a network of firms that I’ve been doing business with, and now my staff has, for years and years where you’re getting a high-quality call. And it’s an early call. I’m not saying we get a call before Fidelity, but quite frankly we get it very often before the big boys.

Also, there are 15 of us at our firm, seven investment professionals plus trading, and we all sit in one big room where we sift through information and make decisions quickly. The larger firms, which are big, bureaucratic, and ponderous, take a long time to process that information, while we’re a boutique and can focus quickly. So we’re getting an early call and can start our research process before others and come to a decision much sooner than these bigger shops, and then get our position established before that big wave hits.

It must help, obviously, that you focus on small caps.

Yes. We’re obviously in the micro- and small-cap area, which I’ve been in for 25 years. There are about 5,000 names under $1.5 billion market cap, so the playing field is large and analyst coverage is slim. Whereas there are between 15 and 17 firms covering mid-cap and large-cap stocks on average, there are only three or four firms in our area of the market. So it’s an inefficient area of the marketplace. If you’re willing to dig in, roll up your sleeves and work hard, you can find out information about these small companies that others don’t know and use it to your advantage. A small-cap stock can really move when others discover this information that hopefully we’ve already found out.

How big do you let your stocks grow to before selling?

We sell our stocks when they get to a $2 billion market cap. That’s critical and it really gives us an edge. When a company gets to about $2 billion, they run into the law of large numbers, which is a disadvantage because they’re getting up there bigger and bigger and it’s tougher to keep generating those big growth numbers. But more importantly now you’ve got 10-12 firms covering the stock, not the two or three that were in there. Information is now widely disseminated, people know the story, so we’d much rather sell that one and go back and find a smaller name. This is contrary to most managers that let the winners run or expand the definition of what small cap is, stretching the upper boundary. We have always been purely small cap.

What are your buy criteria?


We have six buy criteria, and they haven’t changed in 25 years when I started managing money in 1976. Firstly, the stock’s got to have dramatically accelerated earnings. As a manager we have no interest whatsoever in a company that’s growing trend line is as high as 30%.

That would be considered a growth stock. Why wouldn’t you own it?

The reason is that 30% growth generally is reflected in the price of the stock. We want something going from 30% to 60% or from 10% to 50% because you have this giant change. We have about 80 names in our portfolio, and our typical company if you look at our forward earnings for next year has earnings projected at 40% year over year. That’s a huge change. If everything remains constant, meaning that the multiples remains the same, then that stock ought to be up 40% because the earnings are up 40% and it’ll go up in line with those earnings. But, more importantly, because we’ve discovered the changed nature before others, and realized it’s now on a higher growth plane, that company is going to get a multiple expansion, and that multiple expansion will drive the stock higher, so we get a double whammy. We’re not interested in singles and doubles, we want triples and home runs.

What are your other criteria?

The second one is a strong balance sheet, strong and improving financials, and no debt or little debt.

Third, we want to have strong company relative price strength, meaning that the stock is acting better than the market. If there’s a number attached to it, generally ours is 70 or better, but the point is if a stock is acting well, hitting new highs, and under accumulation, that’s a good sign as most of the time the market is smarter than we are.

The fourth one is we want the industry the company is in price-wise to be acting well, reflecting good things are happening to the companies in it. Often, you might have a great company with great earning but it’s in an industry that’s under a big cloud. If an industry is under a cloud, maybe it’s a government regulation or something like that, that can absolutely kill the group, so we’ll generally avoid it until that cloud has moved on.

Fifth, we want low institutional ownership.

Why low ownership? That sounds counterintuitive.

Often there are $350 million market cap companies that by definition are micro cap, yet are already over-owned institutionally. If you’ve got Morgan Stanley, Goldman Sachs, and Smith Barney that took them public six months ago, by and large the story is already well known. It might be a good stock, but the difference between a good stock and a great stock is one that really moves and goes up, and that generally has to do with discovery. We want to find something is less well known but is undergoing a change.

That change is the sixth thing we look for: the catalyst. We usually want our catalyst to happen within two to three months.

What is your view of the market going forward and small caps’ place in it?

I think we’re in a secular bear market, where we go sideways for at least a decade. When I got into the securities and investing business in 1972, the Dow first hit 1000. It went until 1982 until it effectively broke through 1000 again, a decade of 10 years when stocks went sideways. I think we’ve got a decade going forward that’s going to be similar to that period where the stock market is going to have a very difficult time. The technology blow off and bear market for tech stocks that we’ve experienced now for two-and-a-half years will continue. That sector should have at least two bear markets, similar to what happened when the Nifty 50 peaked in 1972 right before the 1973-74 bear market and had such high valuations they basically never really recovered in the 1975-76 bull market and suffered again.

What does this mean for small caps?

In terms of small cap versus large cap, you’ve got to remember that for 18 years from August of 1982 through March of 2000 the annualized return for the S&P 500 was about 18%. That was off the charts. The Russell 2000 for that period did about 13%. The Ibbotson studies out of Chicago have shown that the annualized return for stocks this century has been about 9-10%. So to get us back to central tendency we’re going to have a long drawn-out bear market and sideways market and we’ll probably be fortunate to see like 6-7 % returns on the overall markets over the next 10 years.

I also think that where the action is going to be will be in small caps. From 1976 through 1982, after that first awful bear market of 73-74, you went through a period of six to seven years when small caps stocks way outperformed large-cap stocks. The annualized return for the Russell 2000 was roughly 16% for that period of time. The S&P 500 only did 9%, completely the opposite of what happened in that secular bull market from 1982 to 2000. I think you’ll see that again.

Looking forward you still have got so much money that went into index funds where they had to own these large capitalization names. Those sell programs will probably still continue, and they’ll have to find a home, and that home is going to be small- and mid-cap stocks. The reason is they’re still way undervalued relative to large-cap stocks on an earnings to growth rate. Secondly, you’ve got simpler stories you can understand. You don’t have this complicated financial structure where it’s difficult tot figure out what’s off the balance sheets and what’s on them. You’ve got simple, clean stories where maybe at least as far as small-cap growth stocks are concerned they’ve got a neat product or service or something that will be able to grow revenues and earnings almost regardless of the direction of the economy by and large, and the market and investors are going to want to own those names.

What are your thoughts on the immediate months ahead?

I feel we’ve probably bottomed this year and are going to have a pretty good 2003. This issue of confidence for the market is going away now with CEOs and CFOs having to sign off on financial statements. We haven’t seen all of that behind us, but as an issue, management is going to think long and hard before they start playing a lot of games. Also, the market has exerted a lot of discipline on the companies that have had screwy financial statements, and so as an issue I think investor confidence is going to begin to increase. By 2003, with all this behind them, companies may well be saying, “You know, we’ve got some pretty decent numbers.” You’ve also got this mid-election year cycle phenomena, which is pretty regular going all the way back to1934. Mid-election year fall seasons are generally are about the low, so folks will begin to look on the following year with more optimism. We’ve gone through 11 discount rate cuts in the last two-and-a-half years, so you’re beginning to see signs of life.

10 Micro Caps Worth Watching

By John Dutton, Director of Research, JM Dutton & Associates, LLC
www.jmdutton.com

As one of the largest independent equity research firms in the U.S., Dutton & Associates is helping investors gain high-quality fundamental research on good companies. Many of these companies had little or no research coverage prior to us, and as a result have been under Wall Street’s proverbial “radar screen” and trading at prices well below intrinsic value.

Our program of independent research minus any investment banking or brokerage constraints involves a full year of coverage, with an initial report, three quarterly reports, and research notes in between the quarters.

The following are companies we’ve reported on within the last several weeks, whose reports on our site at www.jmdutton.com may be of interest to you:

The Leather Factory (AMEX: TLF $2.93) Rating: Strong Buy
In our September 17 quarterly report, analyst Robert Davis noted that once again, in the second quarter of 2002, The Leather Factory exceeded its prior year results and our earlier estimates by a substantial margin. Total revenues increased 7.4% versus the prior year quarter, while net income rose 27.3%. Continued strong customer demand for its products, and the rapid and successful expansion of its marketing efforts, have led us to increase our revenue and earnings projections for 2002. We now estimate The Leather Factory's 2002 revenues at $41.1 million with fully diluted EPS of $0.27. In spite of the Company's strong performance, its market price has remained static, largely as a result of overall market weakness.

First Cash Financial Services, Inc. (NasdaqNM: FCFS $8.82) Rating: Strong Buy
In our September 17 quarterly update, Richard West, CFA, wrote that he believes that the current market valuation of First Cash does not reflect its excellent financial history, its experienced management in the short-term loan market, nor its potential growth in the coming years. First Cash sells at a relatively low valuation in relation to its historical growth rate of over 25%, with net income growing from $1.1 million in 1994 to a projected $10.2 million in 2002, and is valued low in comparison to its peers. Revenues in 2003 are projected at $125 million with EPS of $1.30.

MEXCO Energy (OTCBB: MEXC $3.20) Rating: Speculative Buy
In our September 18 update report, analyst Les Childress noted he believes the basic story for Mexco Energy Corporation (Mexco) remains intact. We think the pull-back in share price from the recent high of $9 on low volume is linked to a couple of factors. First, there has been no positive development on obtaining an AMEX listing for Mexco, and some investors may have placed more importance on AMEX than is warranted. Second, fiscal year 2002 financial results were less than anticipated. Earnings per share were $0.11 for the year, down $0.09 from our $0.20 estimate. Last year's earnings were $0.86. We were aware that quarterly earnings for the first nine months of fiscal 2002 were running behind year-ago figures, but revenue was on target. In fact, revenue came in about in line, which is good news.

Century Casinos (Nasdaq: CNTY) Rating: Strong Buy
In our September 16 research note, Gerald LaKarnafeaux, CFA, reaffirmed his strong buy rating after the company announced an increase in its credit facility with Wells Fargo Bank to $26 million, providing an additional net borrowing capacity of $14.5 million. The Colorado Division of Gaming recently released the gaming revenue results for the month of July. The Cripple Creek (CC) market generated $13.22 million of Adjusted Gross Proceeds (AGP) or 1.5% over the $13.03 million for July of last year. The next critical date for Century's South Africa operation is September 23. That is the scheduled day for the Pretoria High Court to address the status of the last of the six licenses to own and operate a casino in Johannesburg.

Neurological Technologies, Inc. (Nasdaq: NTII) Rating: Strong Buy
In our September 13 research note, Sherry Grisewood, CFA, reaffirmed her rating, noting that Forest Laboratories, Neurobiological's US development and marketing partner for Memantine, announced positive results for a 6-month Phase III combination therapy trial of Memantine in the treatment of moderate-to-severe Alzheimer's disease. There is currently no FDA-approved therapy for moderate-to-severe Alzheimer's disease. Memantine, in combination with donepezil, produced an improvement in cognition over the course of the study which is in contrast with most other Alzheimer's therapies, which seem to only slow the expected decline in cognition. This study's results seem to track closely with those of prior studies and support the drug's efficaciousness in treating moderate-to-severe disease. In our view, approval risk for Memantine is inching downward with each positive study result.

Warrantech, Inc (OTCBB: WTEC) Rating: Strong Buy
In our September 13 research note, Richard West, CFA, reaffirmed his rating, noting Warrantech announced that the MARTA Cooperative of America has designated W
arrantech as the only "endorsed" provider of extended service contracts for its 100 active owner-members. MARTA represents more than 100 retailers that sell through 450 store fronts domestically with over $2.0 Billion in sales.

Vita Food Products (AMEX: VSF) Rating: Strong Buy
In our September 12 quarterly update, Gerald LaKarnafeaux, CFA, maintained his rating with a 12 month price target of $12, noting: "Our initial report on Vita Food Products listed eight reasons supporting our Strong Buy rating, and we are reaffirming these reasons in our update. Q2 was in line with our expectations. Sales were $8.79 million, 75% above the prior year's $5.03 million. EPS was $.04 compared to the prior year loss of ($.02) per share. There was sales growth in both the herring and the salmon product categories, while the Virginia Honey business contributed sales of over $3.3 million, about one third of the second quarter total. The Company recently announced an agreement to acquire The Halifax Group, a specialty food producer."

Riviera Tool Co. (AMEX: RTC) Rating: Strong Buy
In our September 5 initial report on Riviera Tool Company, Gary Clark, CFA, noted that Riviera Tool is one of the eight leading manufacturers of metal dies used by the automotive industry for the high-speed production of stamped sheet metal parts. The Company and the industry are emerging from a very difficult period. A strong rebound appears to have begun, with RTC's revenues up 61% in the most recent quarter with backlog having more than doubled. Revenues are driven by the number of model changes rather than by the unit volume of automotive output, with many new automobile designs being released or on the horizon. Revenues and EPS are projected at $22.8 million and $.43 in 2002, rising to $26 million and $.63 for 2003. Revenues and EPS in 2001 were $12 million and $(.16) respectively. Our price target of $3.60, a modest P/E of 5.7x 2003 EPS.

ENGlobal (AMEX: ENG) Rating: Buy
In our September 4 initial report, analyst Robert Davis noted, "With revenues increasing from $12.2 million in 1999 to an estimated $118 in 2002, ENGlobal is becoming a leading provider of engineering services and engineered systems principally to the pipeline and process industries (primarily refineries and petrochemical manufacturers) throughout the United States and internationally. The Company is the product of a recent merger between two similar entities who individually served differing sub-segments of the petroleum industry. The engineering services is benefiting from the trend toward corporate outsourcing of non-core business activities to outside suppliers, especially true within the petroleum and petrochemicals industries. Prior to this year's merger, both Petrocon and IDS Engineering as independent companies had histories of strong revenue growth, increasing profitability, and positive cash flows. They would have had a 23% compounded annual growth rate if previously combined over the last 14 year period. EPS are estimated at $.08 in 2002 on revenues of $93 million, increasing to $.16 and $118 million in 2003 respectively. Our 12 month price target is $2 to $4, reflecting its strengths, increasing earnings, and peer comparisons."

Medix Resources, Inc. (AMEX: MXR) Rating: Strong Buy
In our September 3 initial report, Paul J. Resnik, CFA, noted the Company is positioned to play a significant role in addressing healthcare costs. Its suite of connectivity solutions for the healthcare industry aim at significantly reducing the 30% of healthcare costs that go to backroom administration and to resolve adverse health events caused by inaccurate or unavailable patient information. With 14% of the U.S.'s GDP spent on healthcare and rising, the inability of the systems of the healthcare industry's participants to communicate efficiently and accurately is costly and inefficient. Medix addresses this problem with partners such as WellPoint Pharmacy Management. Medix launched this year its first market program in Georgia, and is planning to move to five markets during the next 12 months. Assuming a gradual ramp in penetration of the Georgia market, 2002 revenues should approximate $1.6 million. Assuming early 2003 entry into a second market, and then another in mid-year, 2003 revenues may exceed $25 million, with profitability in the third quarter. Our preliminary projection for 2004 revenues is over $110 million. Based on these revenue projections, our Earnings Model targets per-share results are ($0.08) in 2002, $0.06 in 2003, $0.44 in 2004, and $1.15 in 2005. There are significant risks to the achievement of these performance levels, which are discussed in the report.

EasyLink (Nasdaq: EASY) Rating: Speculative Buy
EasyLink is a leading global provider of services that power the exchange of information between enterprises, their trading communities, and their customers. It serves more than 20,000 companies, including over 400 of the Global 500. In our September 3 initial report, Robert Davis noted that the Company has reorganized itself financially by reducing debt level and eliminated significant excess costs. It now operates cash flow positively, and is on the cusp of becoming profitable. Revenues are forecast at $122 million and $149 million for 2002 and 2003 respectively, with EPS estimated at $(.67) in 2002, rising to $.32 in 2003. EASY is undervalued, both in purely economic terms and in comparison with its peer group. Our 12 month target price is $3.25 versus a $2.50 recent price.

 

© 2002, The SmallCap Manager, An AdviceTrade Publication, Sponsored by JM Dutton & Associates www.jmdutton.com